Tumor-Activated Prodrugs and Selective Cancer Treatment Conference in New York – February 2027

About this conference

This oncology conference takes place in New York on Feb 8, 2027. Abstracts and papers are due by January 7, 2027. It is one of 20 upcoming oncology conferences in New York; the next one after it starts on February 11. It is organized by iPHARMA Conferences.

Aligned with the modern challenges in cancer care, this conference focuses on tumor-activated prodrugs as a promising avenue for selective treatment. Scholars and practitioners will convene to discuss research developments and therapeutic applications. Submissions of original papers and abstracts are welcome, covering topics from drug optimization to patient-centered treatment approaches. The conference program features a variety of engaging sessions including presentations, panel discussions, and workshops that address both theoretical foundations and practical implications for clinicians. Expert speakers will share insights on the drug development pipeline and emerging technologies in targeted therapies. This event provides a unique opportunity for networking and collaboration among professionals in the oncology field. Registration in advance is encouraged for those looking to be part of this important dialogue.